Page 3 - Japanese (NIKKEI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 23, 2024

Discover Japanese Pharmaceuticals & Biotech Growth Stocks that are on the NIKKEI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

90 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4890

Tsubota Laboratory
JP¥440.002.6%5.0%JP¥11.3bn/aPS10.1xn/an/a

4548

Seikagaku
JP¥810.00-0.1%5.3%JP¥44.2bn/aPE21.9xn/a3.7%

4583

Chiome Bioscience
JP¥180.0078.2%32.4%JP¥11.0bn/aPS19xn/an/a

4978

ReproCELL
JP¥114.0010.7%-47.5%JP¥10.7bn/aPS4.1xn/an/a

7079

WDB coco
JP¥3,570.00-1.9%-23.2%JP¥8.6bn/aPE9.1xn/a2.1%

4892

Cyfuse Biomedical K.K
JP¥463.00-3.9%-42.8%JP¥3.7bn/aPS59.9xn/an/a

2370

MEDINET
JP¥40.002.6%-13.0%JP¥10.3bn/an/an/an/a

4570

Immuno-Biological Laboratories
JP¥500.001.4%-9.9%JP¥4.7bn/aPE20.2xn/a0%

4598

Delta-Fly Pharma
JP¥519.00-10.4%-56.5%JP¥4.7bn/aPB6.4xn/an/a

7776

CellSeed
JP¥565.002.2%79.9%JP¥19.6bn/an/an/an/a

2309

CMIC HOLDINGS
JP¥2,644.000.2%26.6%JP¥44.7bn/aPE8.4xn/a1.9%

2929

Pharma Foods International
JP¥951.00-2.8%-28.0%JP¥26.7bn/aPE8.3xn/a2.6%

4896

K PharmaInc
JP¥730.00-1.7%6.4%JP¥8.5bn/an/an/an/a

6190

PhoenixBio
JP¥364.001.1%-24.0%JP¥1.5bn/aPE211xn/an/a

4572

Carna Biosciences
JP¥310.008.0%-63.6%JP¥5.9bn/aPS4.2xn/an/a

4594

BrightPath Biotherapeutics
JP¥56.0012.0%-44.0%JP¥4.6bn/an/an/an/a

4571

NANO MRNALtd
JP¥167.003.1%-35.5%JP¥11.8bn/aPS153.1xn/an/a

4596

Kubota Pharmaceutical Holdings
JP¥62.003.3%-18.4%JP¥3.5bn/aPS132.1xn/an/a

4888

Stella Pharma
JP¥494.002.9%56.8%JP¥16.8bn/aPS59xn/an/a

4894

Cuorips
JP¥5,180.00-1.0%184.5%JP¥41.5bn/aPS1804.5xn/an/a

4534

Mochida Pharmaceutical
JP¥3,315.00-0.5%0.3%JP¥117.5bn/aPE25.9xn/a2.4%

4575

CanBas
JP¥887.00-2.8%-14.1%JP¥17.0bn/aPB5.3xn/an/a

2183

Linical
JP¥346.002.1%-37.3%JP¥7.8bn/aPE30.9xn/a4.6%

4582

SymBio Pharmaceuticals
JP¥255.008.1%-3.4%JP¥11.7bn/aPS3.8xn/an/a
Page 3 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.